FDA Grants Cannabis Extract VER-01 Breakthrough Therapy Status for Pain
Comments Off on FDA Grants Cannabis Extract VER-01 Breakthrough Therapy Status for Pain
June 4, 2026
The FDA has awarded Breakthrough Therapy Designation to VER-01, a pharmaceutical-grade cannabis extract for chronic low back pain. This marks the first FDA breakthrough therapy cannabis designation for pain treatment, backed by Phase 3 trials showing…
Cannabinoids Offer Modest Pain Relief but Fall Short of First-Line Status, Review Concludes
Comments Off on Cannabinoids Offer Modest Pain Relief but Fall Short of First-Line Status, Review Concludes
April 16, 2026
This cannabinoid analgesia review highlights modest, condition-specific pain relief from cannabinoids. Safety concerns and regulatory challenges limit their use to adjunctive therapy. Patients unresponsive to conventional treatments may consider…
Full-Spectrum Cannabis Extract Shows Significant Pain Reduction in Chronic Neuropathic Pain
Comments Off on Full-Spectrum Cannabis Extract Shows Significant Pain Reduction in Chronic Neuropathic Pain
February 23, 2026
If you live with chronic nerve pain, this study provides clinical evidence that full-spectrum cannabis extract chronic neuropathic pain relief can deliver meaningful benefits. A clinical study found that a full-spectrum cannabis extract containing a…